Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Treasury Shares (2020 - 2025)

Tango Therapeutics (TNGX) has 4 years of Treasury Shares data on record, last reported at $1.3 million in Q4 2025.

  • For Q4 2025, Treasury Shares rose 4.47% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, up 4.47%, while the annual FY2025 figure was $1.3 million, 4.47% up from the prior year.
  • Treasury Shares reached $1.3 million in Q4 2025 per TNGX's latest filing, down from $1.3 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.5 million in Q1 2025 and bottomed at $633626.0 in Q1 2023.
  • Average Treasury Shares over 3 years is $1.1 million, with a median of $1.2 million recorded in 2024.
  • Peak YoY movement for Treasury Shares: skyrocketed 97.98% in 2024, then rose 4.47% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $757514.0 in 2023, then soared by 59.64% to $1.2 million in 2024, then rose by 4.47% to $1.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $1.3 million in Q4 2025, $1.3 million in Q3 2025, and $1.4 million in Q2 2025.